Practical applications of vitreous imaging for the treatment of vitreous opacities with YAG vitreolysis.
Dynamic OCT
Floaters
OCT
Scanning laser ophthalmoscopy
Vitreolysis
YAG laser
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
30
01
2022
accepted:
08
06
2023
medline:
18
9
2023
pubmed:
4
7
2023
entrez:
4
7
2023
Statut:
ppublish
Résumé
To demonstrate the methodology and efficacy of using scanning laser ophthalmoscopy (SLO) and dynamic optical coherence tomography (OCT) to identify and treat symptomatic vitreous floaters using yttrium-aluminum garnet laser vitreolysis (YLV). This is a case series highlighted from a cross sectional retrospective study conducted at the Vitreous Retina Macula Specialists of Toronto. Forty eyes from thirty-five patients were treated with YLV between November 2018 and December 2020 for symptomatic floaters and imaged with SLO and dynamic OCT. Patients were re-treated with YLV if they reported ongoing significant vision symptoms during follow-up which correlated to visible opacities on exam and or imaging. Three cases will be highlighted to present the practical applications of SLO and dynamic OCT imaging for YLV treatment. Forty treated eyes were enrolled in this study, with twenty-six eyes (65%) requiring at least one repeat YLV treatment following the first treatment due to ongoing symptomatic floaters. Following the first YLV, there was a significant improvement in overall mean best corrected visual acuity compared to before treatment (0.11 ± 0.20 LogMAR units vs. 0.14 ± 0.20 LogMAR units, p = 0.02 (paired t test)). Case 1 demonstrates a dense, solitary vitreous opacity that has been localized with dynamic OCT imaging to track its movements and retinal shadowing with the patient's eye movements. Case 2 shows the utility of adjusting the fixation target to monitor the movement of vitreous opacities in real-time. Case 3 exhibits an association between decreased symptom burden and vitreous opacity density after YLV. Image-guided YLV facilitates the localization and confirmation of vitreous opacities. SLO and dynamic OCT of the vitreous can provide a real-time evaluation of floater size, movement, and morphology, to help clinicians target treatment and monitoring of symptomatic floaters.
Identifiants
pubmed: 37402010
doi: 10.1007/s10792-023-02765-4
pii: 10.1007/s10792-023-02765-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3587-3594Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Luo J, An X, Kuang Y (2018) Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters. J Int Med Res 46:4465–4471. https://doi.org/10.1177/0300060518794245
doi: 10.1177/0300060518794245
pubmed: 30200800
pmcid: 6259370
Singh IP (2018) Novel OCT application and optimized YAG laser enable visualization and treatment of mid- to posterior vitreous floaters. Ophthal Surg Lasers Imaging Retin 49:806–811. https://doi.org/10.3928/23258160-20181002-10
doi: 10.3928/23258160-20181002-10
Shah CP, Heier JS (2017) YAG laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters. JAMA Ophthalmol 135:918. https://doi.org/10.1001/jamaophthalmol.2017.2388
doi: 10.1001/jamaophthalmol.2017.2388
pubmed: 28727887
pmcid: 5710539
Sebag J, Yee KMP, Wa CA et al (2014) Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile. Retina 34:1062–1068. https://doi.org/10.1097/IAE.0000000000000065
doi: 10.1097/IAE.0000000000000065
pubmed: 24296397
Zou H, Liu H, Xu X, Zhang X (2013) The impact of persistent visually disabling vitreous floaters on health status utility values. Qual Life Res 22:1507–1514. https://doi.org/10.1007/s11136-012-0256-x
doi: 10.1007/s11136-012-0256-x
pubmed: 23054488
Milston R, Madigan MC, Sebag J (2016) Vitreous floaters: etiology, diagnostics, and management. Surv Ophthalmol 61:211–227. https://doi.org/10.1016/j.survophthal.2015.11.008
doi: 10.1016/j.survophthal.2015.11.008
pubmed: 26679984
Ivanova T, Jalil A, Antoniou Y et al (2016) Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review. Eye 30:645–655. https://doi.org/10.1038/eye.2016.30
doi: 10.1038/eye.2016.30
pubmed: 26939559
pmcid: 4869141
Shaimova VA, Shaimov TB, Ryzhkov PK, et al (2018) Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters. Vestn Oftal’mologii 134:56. https://doi.org/10.17116/oftalma2018134156-62
Tripathy K (2017) Is Floaterectomy Worth the Risks? Asia-Pacific J Ophthalmol 176:384–386. https://doi.org/10.22608/APO.201738
Sommerville DN (2015) Vitrectomy for vitreous floaters: analysis of the benefits and risks. Curr Opin Ophthalmol 26:173–176. https://doi.org/10.1097/ICU.0000000000000150
doi: 10.1097/ICU.0000000000000150
pubmed: 25784107
Kokavec J, Wu Z, Sherwin JC, et al (2017) Nd: YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters. Cochrane Database Syst Rev 2017. https://doi.org/10.1002/14651858.CD011676.pub2
Tian J, Zhang J, Yuan G et al (2019) Nd:YAG laser vitreolysis for symptomatic vitreous floaters: application of infrared fundus photography in assessing the treatment efficacy. J Ophthalmol 2019:1–7. https://doi.org/10.1155/2019/8956952
doi: 10.1155/2019/8956952
Nguyen JH, Nguyen-Cuu J, Yu F et al (2019) Assessment of vitreous structure and visual function after neodymium:Yttrium–Aluminum–Garnet laser vitreolysis. Ophthalmology 126:1517–1526. https://doi.org/10.1016/j.ophtha.2019.06.021
doi: 10.1016/j.ophtha.2019.06.021
pubmed: 31471088
Delaney YM, Oyinloye A, Benjamin L (2002) Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye 16:21–26. https://doi.org/10.1038/sj.eye.6700026
doi: 10.1038/sj.eye.6700026
pubmed: 11913884
Peyman GA (1984) Contact lenses for Nd: Yag application in the vitreous. Retina 4:129–131. https://doi.org/10.1097/00006982-198400420-00012
doi: 10.1097/00006982-198400420-00012
pubmed: 6540469
Su D, Shah CP, Hsu J (2020) Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption. Surv Ophthalmol 65:589–591. https://doi.org/10.1016/j.survophthal.2020.02.007
doi: 10.1016/j.survophthal.2020.02.007
pubmed: 32135173
Souza CE, Lima LH, Nascimento H et al (2020) Objective assessment of YAG laser vitreolysis in patients with symptomatic vitreous floaters. Int J Retin Vitr 6:1–5. https://doi.org/10.1186/s40942-019-0205-8
doi: 10.1186/s40942-019-0205-8
Serpetopoulos CN, Korakitis RA (1998) An optical explanation of the entoptic phenomenon of “clouds” in posterior vitreous detachment. Ophthalmic Physiol Opt 18:446–451. https://doi.org/10.1016/S0275-5408(98)00018-0
doi: 10.1016/S0275-5408(98)00018-0
pubmed: 10023478
Mamou J, Wa CA, Yee KMP et al (2015) Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life. Investig Ophthalmol Vis Sci 56:1611–1617. https://doi.org/10.1167/iovs.14-15414
doi: 10.1167/iovs.14-15414
Garcia GA, Khoshnevis M, Yee KMP et al (2016) Degradation of contrast sensitivity function following posterior vitreous detachment. Am J Ophthalmol 172:7–12. https://doi.org/10.1016/j.ajo.2016.09.005
doi: 10.1016/j.ajo.2016.09.005
pubmed: 27633841
Garcia GA, Khoshnevis M, Yee KMP et al (2018) The effects of aging vitreous on contrast sensitivity function. Graefe’s Arch Clin Exp Ophthalmol 256:919–925. https://doi.org/10.1007/s00417-018-3957-1
doi: 10.1007/s00417-018-3957-1
Ringel MJ, Tang EM, Tao YK (2021) Advances in multimodal imaging in ophthalmology. Ther Adv Ophthalmol 13:251584142110024. https://doi.org/10.1177/25158414211002400
doi: 10.1177/25158414211002400
Katsanos A, Tsaldari N, Gorgoli K et al (2020) Safety and efficacy of YAG laser vitreolysis for the treatment of vitreous floaters : an overview. Adv Ther. https://doi.org/10.1007/s12325-020-01261-w
doi: 10.1007/s12325-020-01261-w
pubmed: 33108623
pmcid: 7854404